"We are strong supporters of the global effort, which India is part of, called COVAX, which is a multilateral initiative to procure vaccines at scale and then distribute them through the GAVI vaccine alliance to countries including India".
It is noted that in 2021, UNICEF plans to provide the supply of half a billion syringes for immunization against coronavirus - besides 620 million syringes for vaccination against measles, typhoid and more. This has paved the way for Indian vaccine makers, which manufacture more than 60% of all vaccines sold globally, to take center stage.
Alongside the 92 low- and middle-income economies eligible for support by the Gavi COVAX AMC, 78 higher-income economies, which will finance their own vaccines, have now joined the COVAX Facility, a global effort to ensure rapid and equitable access to safe and effective COVID-19 vaccines for the most vulnerable groups across the world.
Download photos and broll here, including special syringe broll at the world's largest humanitarian warehouse in Copenhagen, run by UNICEF, and from South Sudan on syringes and solar fridges being used at a health centre.
Last week, the UAE Ministry of Health and Prevention approved Phase III trials of the Sputnik V vaccine.
"They also provided the platform that looks at related issues which is empowering scientific leadership in developing countries, particularly women, to think about what the long-term issues of the future are going to be or the present and the future, including but beyond COVID-19", he said. Intranasal vaccine is a nasal spray that is directly sprayed into the nose to help protect against the Influenza and is not a Covid-19 vaccine.
Washington University School of Medicine in St. Louis, Missouri has licensed a single dose intranasal vaccine for coronavirus disease to Bharat Biotech, a leading vaccine and bio-therapeutics manufacturer.
The institute has said it hopes the vaccine to be ready by December and expects licensing for distribution in India by March.
A total of 184 countries and economies have joined The Covid-19 Vaccines Global Access (Covax) Facility, an worldwide initiative co-led by the World Health Organization (WHO) and partners to ensure effective and equitable global access to Covid-19 vaccines, the WHO chief announced. Experts are also in the phase of confusion as nothing can be predicted about the results of the Covid-19 vaccines been developed in India and all over the world. Post-registration clinical trials have been launched in Russian Federation involving more than 40,000 people in the second week of August 2020.
In the meantime, plans are afoot with the Indian players to ramp up capacities to cater to the increasing demand. It is the 1st registered vaccine in the world against the virus, developed by using human adenoviral vectors.
India is also producing at least a dozen indigenous vaccines.